// App-Quantinova.ai

416 : Efficacy and Safety of Biological DMARDs: A Systematic Literature Review Informing the 2022 Update of the ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis

Researchers

Presenter

  • Casper Webers

Principal Investigators

  • Augusta Ortolan

  • Alexandre Sepriano

  • Louise Falzon

  • Xenofon Baraliakos

  • Robert Landewé

  • Sofia Ramiro

  • Désirée van der Heijde

  • Elena Nikiphorou

Medical Centers

  • Maastricht University Medical Center, Maastricht, Netherlands

  • University of Padova/Leiden University Medical Center, Padova, Italy

  • Leiden University Medical Centre, Portela Loures, Portugal

  • Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom

  • Rheumazentrum Ruhrgebiet, Herne, Germany

  • Amsterdam University Medical Center, Overveen, Netherlands

  • Leiden University Medical Centre, Leiden, Netherlands

  • Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Leiden, Netherlands

  • Leiden University Medical Center & King's College London, London, United Kingdom

Locations

  • Netherlands

  • Italy

  • Portugal

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Non-radiographic axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Observational

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved